Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

VYNE Therapeutics Stock News

VYNENASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

VYNE Therapeutics (VYNE) Forecast

News

Earnings VYNE Therapeutics (VYNE) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest VYNE Therapeutics Stock News | NASDAQ:VYNE | Benzinga

Get the latest news on VYNE Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on VYNE Therapeutics performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, April 25, 2025

12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights - Apr 25, 2025, 1:06PM
FDA Puts VYNE Therapeutics Early-Stage Psoriasis Study On Hold
Vandana Singh - Apr 25, 2025, 11:55AM
HC Wainwright & Co. Maintains Buy on VYNE The...
Benzinga Newsdesk - Apr 25, 2025, 10:14AM
VYNE Therapeutics shares are trading lower af...
Benzinga Newsdesk - Apr 25, 2025, 8:22AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights - Apr 25, 2025, 8:09AM
FDA Places Clinical Hold On VYNE Therapeutics...
Benzinga Newsdesk - Apr 25, 2025, 8:07AM

Thursday, March 20, 2025

Vyne Therapeutics To Present At Autoimmune & ...
Benzinga Newsdesk - Mar 20, 2025, 8:04AM

Tuesday, March 11, 2025

Why Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Avi Kapoor - Mar 11, 2025, 6:55AM

Thursday, March 06, 2025

VYNE Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Benzinga Insights - Mar 6, 2025, 2:02PM
HC Wainwright & Co. Reiterates Buy on VYNE Th...
Benzinga Newsdesk - Mar 6, 2025, 2:00PM
VYNE Therapeutics Q4 2024 GAAP EPS $(0.28) Be...
Benzinga Newsdesk - Mar 6, 2025, 8:12AM

Wednesday, February 19, 2025

HC Wainwright & Co. Reiterates Buy on VYNE Th...
Benzinga Newsdesk - Feb 19, 2025, 11:12AM
VYNE Therapeutics Initiates Phase 1b Trial Of...
Benzinga Newsdesk - Feb 19, 2025, 8:01AM

Tuesday, January 14, 2025

HC Wainwright & Co. Reiterates Buy on VYNE Th...
Benzinga Newsdesk - Jan 14, 2025, 7:07AM

Monday, January 06, 2025

Forecasting The Future: 4 Analyst Projections For VYNE Therapeutics
Benzinga Insights - Jan 6, 2025, 1:00PM
HC Wainwright & Co. Reiterates Buy on VYNE Th...
Benzinga Newsdesk - Jan 6, 2025, 11:12AM
Vyne Therapeutics Has Completed Enrollment In...
Benzinga Newsdesk - Jan 6, 2025, 7:32AM

Monday, December 23, 2024

HC Wainwright & Co. Reiterates Buy on VYNE Th...
Benzinga Newsdesk - Dec 23, 2024, 9:54AM
VYNE Therapeutics Reports Results from Phase ...
Benzinga Newsdesk - Dec 23, 2024, 7:32AM

Monday, November 18, 2024

BTIG Initiates Coverage On VYNE Therapeutics ...
Benzinga Newsdesk - Nov 18, 2024, 8:39AM

Friday, November 08, 2024

HC Wainwright & Co. Reiterates Buy on VYNE Th...
Benzinga Newsdesk - Nov 8, 2024, 5:11AM

Thursday, November 07, 2024

VYNE Therapeutics Q3 2024 GAAP EPS $(0.29) Mi...
Benzinga Newsdesk - Nov 7, 2024, 8:19AM
VYNE Therapeutics Q3 EPS $(0.29) Misses $(0.2...
Benzinga Newsdesk - Nov 7, 2024, 8:19AM

Thursday, September 12, 2024

HC Wainwright & Co. Reiterates Buy on VYNE Th...
Benzinga Newsdesk - Sep 12, 2024, 11:33AM
VYNE Therapeutics Announces Phase 1a SAD Data...
Benzinga Newsdesk - Sep 12, 2024, 8:13AM

Thursday, August 15, 2024

HC Wainwright & Co. Reiterates Buy on VYNE Th...
Benzinga Newsdesk - Aug 15, 2024, 5:57AM

Wednesday, August 14, 2024

VYNE Therapeutics Q2 2024 GAAP EPS $(0.22) Mi...
Benzinga Newsdesk - Aug 14, 2024, 8:07AM

Tuesday, July 16, 2024

VYNE Therapeutics Announces Composition Of Ma...
Benzinga Newsdesk - Jul 16, 2024, 8:05AM

Thursday, June 20, 2024

12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights - Jun 20, 2024, 12:32PM

Friday, June 14, 2024

Analyst Scoreboard: 4 Ratings For VYNE Therapeutics
Benzinga Insights - Jun 14, 2024, 9:01AM
HC Wainwright & Co. Reiterates Buy on VYNE Th...
Benzinga Newsdesk - Jun 14, 2024, 6:01AM

Thursday, June 13, 2024

VYNE Therapeutics Doses First Volunteers In P...
Benzinga Newsdesk - Jun 13, 2024, 9:04AM

Wednesday, June 05, 2024

HC Wainwright & Co. Reiterates Buy on VYNE Th...
Benzinga Newsdesk - Jun 5, 2024, 11:21AM
VYNE Therapeutics Doses First Subject In Phas...
Benzinga Newsdesk - Jun 5, 2024, 8:01AM

Thursday, May 09, 2024

HC Wainwright & Co. Reiterates Buy on VYNE Th...
Benzinga Newsdesk - May 9, 2024, 11:27AM
VYNE Therapeutics Q1 EPS $(0.15) Beats $(0.24...
Benzinga Newsdesk - May 9, 2024, 9:06AM

Monday, May 06, 2024

HC Wainwright & Co. Reiterates Buy on VYNE Th...
Benzinga Newsdesk - May 6, 2024, 10:45AM
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - May 6, 2024, 8:06AM
VYNE Therapeutics Announces FDA Clearance Of ...
Benzinga Newsdesk - May 6, 2024, 8:04AM

Wednesday, May 01, 2024

VYNE Therapeutics Presents VYN201 At 2024 SID...
Benzinga Newsdesk - May 1, 2024, 8:45AM

Friday, March 29, 2024

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights - Mar 29, 2024, 4:30PM

Thursday, February 29, 2024

HC Wainwright & Co. Reiterates Buy on VYNE Th...
Benzinga Newsdesk - Feb 29, 2024, 3:06PM
Recap: VYNE Therapeutics Q4 Earnings
Benzinga Insights - Feb 29, 2024, 8:30AM
VYNE Therapeutics Ended 2023 With $93.3M Of C...
Benzinga Newsdesk - Feb 29, 2024, 8:12AM
VYNE Therapeutics Q4 Adjusted EPS $(0.18) Bea...
Benzinga Newsdesk - Feb 29, 2024, 8:12AM

Tuesday, February 27, 2024

VYNE Therapeutics To Present Results Of Phase...
Benzinga Newsdesk - Feb 27, 2024, 8:14AM

Tuesday, January 16, 2024

Top 4 Health Care Stocks That May Rocket Higher In Q1
Avi Kapoor - Jan 16, 2024, 6:50AM

Thursday, January 11, 2024

Why Richardson Electronics Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
Avi Kapoor - Jan 11, 2024, 7:51AM

Wednesday, January 10, 2024

VYNE Therapeutics Announces Biomarker Data Fr...
Benzinga Newsdesk - Jan 10, 2024, 8:04AM

Monday, November 13, 2023

VYNE Therapeutics Q3 Adj EPS $(1.59) Beats $(...
Benzinga Newsdesk - Nov 13, 2023, 7:50AM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved